DrugInfoSys

Phenytoin (Na)

Also known as: Diphenyl hydantoin Na, Phenytoin

Drug #570

Phenytoin (Na) is oral and parenteral hydantoin anticonvulsant first synthesized in 1908. Although it has been used in many diverse conditions, its only approved use is as an anticonvulsant, specifically, for the prophylactic management of tonic-clonic seizures and partial seizures with complex symptomatology. Anticonvulsant drugs can elevate the seizure threshold and/or limit the spread of seizure discharge. Phenytoin exerts its anticonvulsant effect mainly by limiting the spread of seizure activity and reducing seizure propagation, unlike phenobarbital and carbamazepine, which elevate the seizure threshold. Phenytoin was originally approved by the FDA in 1939.

Primary Characteristics

Phenytoin (Na) is also known as Diphenyl hydantoin Na, Phenytoin.

It is of Natural origin and belongs to Imidazolidinedione.

It belongs to Na-Channel Antagonist pharmacological group on the basis of mechanism of action.

Molecular Weight: 274.3 · pKa: 8.3 · Solubility in Water: 1 in 66 · Solubility in Alcohol: 1 in 10.5 · Non-proprietary name: Phenytoin (Na).

Molecular structure of Phenytoin (Na)

Pharmacokinetics

Absorption: Phenytoin (Na) has an oral bioavailability is 92.5% (±2.5%).

Distribution: Phenytoin (Na) has a volume of distribution is 0.5 - 0.7 l/kg. plasma protein binding is 90 - 93 %.

Elimination: plasma half-life is 7 - 60 hr, renal excretion is < 5 %.

Advertisement

Indications

Contraindications

Phenytoin (Na) is contraindicated in conditions like Porphyrias.

Dosage

Phenytoin (Na)'s dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
225 mg225 mgEvery 24hPO
Paediatric Dosage (20kg)
4.1254.125Every 12hOral For Children 3-6 Yrs of Age
Neonatal Dosage (3kg)
4.5 mg/kg4.5 mg/kgEvery 12hIntravenousFor 6 months and above children

Drug Interactions

Unknown150 interactions
58 interactions
Major4 interactions
Minor2 interactions
Moderate16 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Phenytoin (Na) in overdosage may give rise to further complications which include Ataxia , Nausea , Vomiting , Hypotension , Drowsiness , Stupor , Blurred vision , Hyperglycemia , Nystagmus , Coma .

Phenytoin (Na) produces potentially life-threatening effects which include Hepatitis , Dermatitis . Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Phenytoin (Na) are Death .

Phenytoin (Na) is known to cause more or less tolerable side effects which are usually transient. These include Elevated alkaline phosphatase, Folate deficiency, Hypocalcemia, Skin rashesX.

Warnings / Precautions

Phenytoin should be used with caution in patients with liver, lungs, heart diseases and blood disorders. Perform blood counts before initiating the therapy. Administer cautiously in the presence of advanced atrioventricular (AV) block. Do not exceed an I/V infusion rate of 50mg/min. Discontinue use if skin rashes appear.

Interference in Pathology

Phenytoin (Na) may interfere in the diagnosis of Increased Alkaline Phosphatase Levels, Increased blood glucose level, Elevations of gamma glutamyl transpeptidase.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Storage Conditions

Phenytoin (Na) should be stored Caps, Syrup. Inj.

Drug Classification

  1. 1.5Anticonvulsants and Antiepileptics

Manufacturers

Manufacturers of Phenytoin (Na) in Pakistan: